home.social

#celltrion — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #celltrion, aggregated by home.social.

fetched live
  1. Samsung Biologics, Celltrion Post Record Quarterly Revenue; Tech Exports Drive Q2 Pharma, Biotech Earnings — BigGo Finance

    South Korea’s major pharmaceutical and biotech companies achieved across-the-board top-line growth in the second quarter of this year,…
    #EuropeSays #Korea #KR #SamsungBiologics #Celltrion #ChongKunDang #DaewoongPharmaceutical #EliLilly #HanmiPharmaceutical #JanssenBiotech #Lazertinib #Samsung #Sonpeglutide #YuhanCorp.
    europesays.com/korea/120648/

  2. Samsung Biologics Proposes Post-Adjustment First to Break Prolonged Labor Deadlock — BigGo Finance

    Samsung Biologics has taken the initiative to propose post-adjustment proceedings to bring an end to wage and collective…
    #EuropeSays #Korea #KR #SamsungBiologics #Celltrion #ExcessProfitIncentive(OPI) #IncheonRegionalLaborRelationsCommission #ParkJae-sung #Samsung #SamsungBiologicsSangsaengUnion
    europesays.com/korea/119181/

  3. Celltrion’s record quarter sparks target-price upgrades

    Newer products lift margins and growth outlook as UBS names Celltrion its top Korean healthcare pick Celltrion Plant…
    #EuropeSays #Korea #KR #Celltrion #K-Pop
    europesays.com/korea/110734/

  4. Samsung Biologics First-Half Operating Profit Tops ₩1 Trillion; Annual Revenue of ₩5 Trillion Within Reach — BigGo Finance

    Samsung Biologics (207940) has surpassed ₩1 trillion (approximately $678.2 million) in half-year operating profit for the first time…
    #EuropeSays #Korea #KR #SamsungBiologics #BioCampus3 #Celltrion #GLP-1 #GSK #JohnRim #Netherlandssalesoffice #peptide #Plant5 #PolyPeptideGroup #Rockvilleproductionfacility #Samsung
    europesays.com/korea/97114/

  5. South Korea Slams Brakes on Leveraged ETF Regulation; UBS Maintains KOSPI 9,200 Target but Warns of Heightened Volatility — BigGo Finance

    South Korea’s financial regulatory authorities have finally cracked down on single-stock leveraged ETFs, which are widely blamed for…
    #EuropeSays #Korea #KR #BankofKorea #BOK #Celltrion #KOSPI #SamsungE&A #SamsungElectronics #Shinsegae #single-stockleveragedETFs #SKhynix #SouthKorea'sFinancialServicesCommission #UBS
    europesays.com/korea/90334/

  6. europesays.com/ch/104986/ South Korea Slams Brakes on Leveraged ETF Regulation; UBS Maintains KOSPI 9,200 Target but Warns of Heightened Volatility — BigGo Finance #BankOfKorea #Celltrion #KOSPI #SamsungE&A #SamsungElectronics #Shinsegae #SingleStockLeveragedETFs #SKHynix #SouthKorea'sFinancialServicesCommission #UBS

  7. Samsung’s Lee Jae-yong Hits $39.5 Billion, SK’s Chey Tae-won Joins $10 Trillion Won Club as Chaebol Wealth Gap Widens — BigGo Finance

    The stock wealth of South Korea’s major conglomerate heads swelled by more than 29 trillion won (approximately $19.4…
    #EuropeSays #Korea #KR #SK #BangSi-hyuk #Celltrion #CheyTae-won #ChungEui-sun #hybe #HyundaiMotorGroup #Kakao #KimBeom-su #KoreaCXOInstitute #LeeJae-yong #SamsungElectronics #SeoJung-jin #SKGroup #SKInc
    europesays.com/korea/85296/

  8. Keytruda Patent Expires in Two Years; Samsung Bioepis Targets 47 Trillion Won Market with In-House Technology

    As Samsung Bioepis secures subcutaneous injection (SC) formulation technology on its own, the global biosimilar competition is expanding…
    #EuropeSays #Korea #KR #SamsungBiologics #Alteogen #biosimilar #Celltrion #Keytruda #PH20technology #Samsung #SamsungBioepis #SCformulation
    europesays.com/korea/84352/

  9. Samsung to Invest 140 Trillion Won in Chungcheong, President Lee Praises

    President Lee Jae-myung looks at AR glasses ahead of a national briefing on the vision for advanced industry…
    #EuropeSays #Korea #KR #SouthKorea #advancedindustries #AIera #Celltrion #Chungcheonginvestment #LeeJaeMyung #Samsung #semiconductors #SKhynix
    europesays.com/korea/71877/

  10. Samsung, Lotte vie for CDMO supremacy as K-bio storms BIO USA


    Graphics by AJP Song Ji-yoon
     

    SEOUL, June 22 (AJP) – South Korean chips are not…
    #EuropeSays #Korea #KR #SamsungBiologics #biologics #biosimilar #Celltrion #LotteBiologics #Regulation #Samsung #SouthKorea #tariff #u-s
    europesays.com/korea/63681/

  11. K-Bio Courts Big Pharma With AI; Celltrion Books 150 Meetings

    “After Cenobamate, our epilepsy treatment, was commercialized, one of the answers we reached after agonizing over how to…
    #EuropeSays #Korea #KR #SamsungBiologics #AIdrugdevelopment #AstraZeneca #BIOUSA2026 #Celltrion #Galux #Insilico #Samsung #SKBiopharmaceuticals
    europesays.com/korea/62825/

  12. K-Bio Courts Big Pharma With AI; Celltrion Books 150 Meetings

    “After Cenobamate, our epilepsy treatment, was commercialized, one of the answers we reached after agonizing over how to…
    #EuropeSays #Korea #KR #SamsungBiologics #AIdrugdevelopment #AstraZeneca #BIOUSA2026 #Celltrion #Galux #Insilico #Samsung #SKBiopharmaceuticals
    europesays.com/korea/62229/

  13. Korean CDMOs Link Songdo to U.S. Plants in Global Race for Orders

    The world’s largest biotech industry event, “BIO USA,” opened on June 22 (local time). Yonhap News South Korean…
    #EuropeSays #Korea #KR #SamsungBiologics #BIOUSA2026 #biopharmaceutical #biosimilar #CDMO #Celltrion #Korea-U.S.productionnetwork #LotteBiologics #Samsung
    europesays.com/korea/61469/

  14. D-7 to ‘BIO USA’: Korean Firms Mobilize for Licensing, CDMO Megadeals

    The 2025 BIO USA event held at the Boston Convention & Exhibition Center in the U.S. is crowded…
    #EuropeSays #Korea #KR #SamsungBiologics #BIOUSA2026 #CDMO #Celltrion #Koreabiotech #LotteBiologics #pharmaceuticalpartnering #Samsung #technology-transfer
    europesays.com/korea/52612/

  15. D-7 to ‘BIO USA’: Korean Firms Mobilize for Licensing, CDMO Megadeals

    The 2025 BIO USA event held at the Boston Convention & Exhibition Center in the U.S. is crowded…
    #EuropeSays #Korea #KR #SamsungBiologics #BIOUSA2026 #CDMO #Celltrion #Koreabiotech #LotteBiologics #pharmaceuticalpartnering #Samsung #technology-transfer
    europesays.com/korea/52138/

  16. Labor disputes emerge as new risk for Samsung Biologics, Celltrion

    Samsung struggles to break labor deadlock, while Celltrion prepares for first union A crosswalk light is seen in…
    #EuropeSays #Korea #KR #Samsung #Celltrion #SamsungBiologics #SamsungGroup
    europesays.com/korea/48909/

  17. Celltrion Inc stock (KR7068270008): labor union launch and U.S. direct-sales gains in focus

    Celltrion shares on the Korea Exchange traded steady on 06/01/2026 as South Korea-based employees formed the companys first…
    #EuropeSays #Korea #KR #KoreaExchange #Celltrion #KR7068270008 #KRX
    europesays.com/korea/37874/

  18. The #Celltrion #DiaTrust #COVID test has very odd nasal swabs. 2 out of 2 times, they tickled the inside of my nose so much I had a minor sneezing fit. Probably not a good thing if you’re infectious?

  19. The #Celltrion #DiaTrust #COVID test has very odd nasal swabs. 2 out of 2 times, they tickled the inside of my nose so much I had a minor sneezing fit. Probably not a good thing if you’re infectious?

  20. The #Celltrion #DiaTrust #COVID test has very odd nasal swabs. 2 out of 2 times, they tickled the inside of my nose so much I had a minor sneezing fit. Probably not a good thing if you’re infectious?

  21. The #Celltrion #DiaTrust #COVID test has very odd nasal swabs. 2 out of 2 times, they tickled the inside of my nose so much I had a minor sneezing fit. Probably not a good thing if you’re infectious?

  22. The #Celltrion #DiaTrust #COVID test has very odd nasal swabs. 2 out of 2 times, they tickled the inside of my nose so much I had a minor sneezing fit. Probably not a good thing if you’re infectious?